Evidence map›Paper›PMID 29235261›Full record

ArticleImmunity, inflammation and disease2018

Interferon α2 and interferon γ induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells.

Sharon A Oldford, Suzanne P Salsman, Liliana Portales-Cervantes, Raidan Alyazidi, Robert Anderson, Ian D Haidl, Jean S Marshall

Open access · goldAbstract read
In one paragraph

Article in Immunity, inflammation and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Mast Cell Responses to Viruses and Pathogen Products.International journal of molecular sciences · 2019
    Review
  11. Review
  12. IRF3 and IRF7 mediate neovascularization via inflammatory cytokines.Journal of cellular and molecular medicine · 2019
    Article
  13. T cells in severe childhood asthma.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Sharon A OldfordDalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.
Suzanne P SalsmanDalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.
Liliana Portales-CervantesDalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.
Raidan AlyazidiDalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.
Robert AndersonDepartment of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
Ian D HaidlDalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.
Jean S MarshallDalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0002-5642-1379
Dalhousie University · CA

Funding

CIHR MOP10966CIHR THC135230
6 · The paper itself

Abstract

backgroundMast cells are resident immune effector cells, often studied in the context of allergic disease. Found in substantial numbers at sites of potential infection they are increased at sites of angiogenesis and can be pivotal for the sensing and clearance of a variety of pathogens. Interferons (IFNs) are cytokines that are critical for host defence against intracellular pathogens. Increased levels of IFNs are observed during viral infection and in autoimmune diseases. IFNs are also widely used therapeutically and have been examined in the therapy of severe asthma.

objectiveTo define the selective human mast cell cytokine and chemokine response following activation with type I or type II IFN's.

methodsThe ability of both IFNα2 and IFNγ to induce cytokine production by human cord blood-derived mast cells was examined in vitro. Cytokine and chemokine production at 6 and 24 h was assessed by multiplex protein analysis. Degranulation was assessed by β-hexosaminidase release. Mast cells were also treated with reovirus or respiratory syncytial virus and their production of CXCL10, IL-1 receptor antagonist (IL-1Ra), and vascular endothelial growth factor (VEGF) examined after 24 h.

resultsIn addition to increased expression of classical IFN response genes, such as CXCL10, small but significant increases in CCL5 and IL-17 production were observed following IFN activation. Notably, human mast cells produced both VEGF and IL-1Ra in a dose dependent manner. These responses occurred in the absence of mast cell degranulation by a mechanism consistent with classical IFN signaling. Both reovirus and respiratory syncytial virus infection of mast cells, were also associated with IFN-dependent IL-1Ra expression. CONCLUSION AND CLINICAL RELEVANCE: Our findings demonstrate that IFNs have profound impact on cytokine and chemokine expression by human mast cells, alone or in the context of viral infection. Mast cell VEGF and IL-1Ra responses to IFNs could impact the regulation of local inflammatory responses and subsequent tissue remodeling.

Indexed as

Cell DegranulationHumansInterferon alpha-2Interferon-gammaInterleukin 1 Receptor Antagonist ProteinMast CellsVascular Endothelial Growth Factor AIFNG protein, humanIL1RN protein, humanInterferon alpha-2Interferon-gammaInterleukin 1 Receptor Antagonist ProteinVascular Endothelial Growth Factor AVEGFA protein, humanCXCL10IL-1Rainterferonsmast cellsreovirusrespiratory syncytial virusVEGF

Identifiers

PMID29235261
PMCPMC5818443
OpenAlexW2773755547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.